Ectosensewas A Belgium Based Medtech Startup Dedicated To Improving Sleep Healthparticularly For Thoseaffected By Sleep Apneafounded In Leuventhecompany Focused On Innovativediagnostic Solutions And Was Acquired By Resmed In October 2021This Acquisition Allowed Ectosenses Technology To Beintegrated Into Resmedaes Portfolio Of Sleep And Respiratory Caresolutions Oneof Ectosenses Key Products Was Thenightowla C Homesleep Apnea Testa Compact And Fda Approved Devicedesigned For Cloud Connected Hometestingthis Deviceutilized Advanced Micro Electronics And Data Scienceto Provideaccuratediagnostics For Sleep Apneaectosenseaimed To Replacetraditional In Lab Sleep Studies With Scalableand Cost Effectivesolutionsbenefiting Both Patients And Healthcareprovidersthecompany Targeted Undiagnosed Sleep Apnea Patients And Offered Tools To Streamlinediagnosis And Treatment Pathwaysemphasizing Accessibility And Affordability
